United Therapeutics | UTHR - Sales Revenues

Stock Price
479.87
Daily Change
1.60 0.33%
Monthly
-2.01%
Yearly
35.49%
Q1 Forecast
455.03

United Therapeutics reported $799.5M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Amarin USD 49.67M 23.07M Sep/2025
Ardelyx USD 110.33M 12.67M Sep/2025
Baxter International USD 2.84B 30M Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Biogen USD 2.53B 70M Sep/2025
BioMarin Pharmaceutical USD 776M 49M Sep/2025
Gilead Sciences USD 7.8B 700M Sep/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Halozyme Therapeutics USD 354M 148M Sep/2025
Insmed USD 142M 34.6M Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
J&J USD 24.6B 610M Dec/2025
Moderna USD 1.02B 878M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
PTC Therapeutics USD 211M 32.1M Sep/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Sarepta Therapeutics USD 399.4M 211.69M Sep/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025
United Therapeutics USD 799.5M 900K Sep/2025
Vertex Pharmaceuticals USD 3.08B 120M Sep/2025